Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

New cytokine-targeted therapies show promise for treating alopecia areata.

New treatments for severe alopecia areata show promise but lack standard approval.

Upadacitinib improved multiple immune-related conditions in one patient.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

JAK inhibitors effectively regrow hair in alopecia areata but hair loss often returns after stopping treatment.

Ritlecitinib successfully treated a child's alopecia universalis after baricitinib failed.

Upadacitinib effectively treats severe alopecia areata and is safe.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Baricitinib is a promising treatment for alopecia areata in the UAE, but there are challenges with data and access.

Tofacitinib can help regrow hair in about 50% of people with moderate-severe alopecia areata.

JAK inhibitors can help regrow hair in alopecia areata but have potential long-term risks and require careful monitoring.

Dupilumab may help hair regrowth in some patients with severe atopic dermatitis, but results vary.

M30 is a promising treatment for preventing hair loss during chemotherapy.

Regrowing scalp hair improves quality of life and reduces anxiety and depression in severe alopecia areata patients.

rwSALT provides precise hair regrowth measurement from scalp photos.

Hair regrowth in Alopecia Areata patients leads to increased satisfaction and reduced stress.

Deuruxolitinib effectively regrows hair in adults with alopecia areata and is well tolerated.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Dupilumab and ustekinumab are promising treatments for alopecia areata, showing significant hair regrowth.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

Baricitinib is effective and safe for long-term treatment of severe alopecia areata.

Etrasimod is safe but not effective for severe alopecia areata, though it may help milder cases.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

Shallot extract from Palu Valley can effectively kill Salmonella typhi.

rwSALT accurately measures hair regrowth in alopecia areata using scalp photos.

The optimal mix of Dendropanax, sea salt, and other extracts can help reduce hair loss.

The AA-IGA scale reliably measures treatment success in alopecia areata by considering both clinician and patient views.